We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

SemBioSys Completes pre-IND Meeting with U.S. FDA for APO AIMilano

News   Aug 12, 2009

 
SemBioSys Completes pre-IND Meeting with U.S. FDA for APO AIMilano
 
 
Advertisement
 

RELATED ARTICLES

Trial of Saliva Test for COVID-19 Launched

News

Scientists from the Innovative Genomics Institute (IGI), the same UC Berkeley group that rapidly popped up a state-of-the-art COVID-19 testing laboratory in March, are now trialing a quicker way to obtain patient samples: through saliva.

READ MORE

Novel Strategy Generates Useful Compounds for Drug Synthesis

News

A team of scientists has designed a novel catalytic method that can generate useful chiral compounds. This new strategy could provide an effective synthetic way to design pharmaceutical products.

READ MORE

Molecules Identified That Shut Down SARS-CoV-2 Polymerase Reaction

News

Researchers have discovered a library of molecules with unique structural and chemical features, capable of inhibiting the SARS-CoV-2 polymerase.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE